Halozyme Therapeutics

2 followers


Halozyme is a biopharmaceutical company bringing disruptive solutions to significantly improve patient experiences and outcomes for emerging and established therapies.

Industries

Headquarters

Stage

Employees

Links

Org chart

Helen Torley
President & CEO

Helen Torley

Collapse
Al Kildani
Vice President of Investor Relations and Corporate Communications
Alison A. Armour
Senior Vice President, Research and Development
Benjamin J. Hickey
Senior Vice President, Chief Commercial Officer
Dimitrios Chondros
Senior Vice President, Chief Medical Officer
Ed Gemo
Vice President, Chief Information & Security Officer
Elaine Sun
SVP, CFO
Harry J. Leonhardt
Senior Vice President, General Counsel and Corporate Secretary
Homa Yeganegi
Senior Vice President, Global PEGPH20 Program Lead
Laurie D. Stelzer
Senior Vice President & Chief Financial Officer
Michael E. Paolucci
Vice President and Chief Human Resources Officer
Michael J. Labarre
Vice President, Product Development and Regulatory Affairs
William J. Fallon
Senior Vice President, Global ENHANZE Program Lead, CMC Operations & Strategic Alliances
Beth Clarke
Vice President And Cio, It, Security And Site Ops
Christopher Bryant
Senior Vice President, Technical Operations &. Chief Manufacturing Officer
Amy Fox
Vice President, CHRO
Gary Grote
Svp, Chief Commercial Officer
Shelby King
Director, Medical Communications And Publications
Silvia Schneiders Filippi
Associate Director Of Marketing
Michael Travanty
Vice President Of Product Development Engineering
Stephen Knowles
Chief Medical Officer
Anna-Maria Hays Putnam
Vice President, Development And Manufacturing
Danielle Turner
Senior Director, Regulatory Affairs
Michael Vanderwerf
Vice President Regulatory Affairs
Nithila Duraisamy
Director - Regulatory Affairs
Robert Markovich
Executive Director, Analytical & Characterization Development
Sara Coon
Director Regulatory Affairs - Devices
Dana Schramm
Executive Director, Manufacturing Engineering, Materials, And Supply Chain
Gilbert Keller
Senior Research Fellow And Executive Director
Kevin McAdams
Vice President, Managed Markets